Statins are one of the most well-studied class of drugs and the benefits of statins in the
treatment and prevention of both cardiovascular and cerebrovascular disease are well …

Introduction: Statin monotherapy is generally well tolerated, with a low frequency of adverse
events. The most important adverse effects associated with statins are myopathy and an …

3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors (the so-called statins:
atorvastatin, fluvastatin, pravastatin, lovastatin, rosuvastatin and simvastatin) are a well …

The statins are widely used worldwide to reduce risk for cardiovascular events in both the
primary and secondary prevention settings. Although generally quite safe, the statins can be …

Background: As the clinical complexity of patients at high cardiovascular risk and with
multiple comorbid conditions increases, so does the potential for drug–drug interactions …

A n D GUID eLIneS affordability may often dictate which medications may be prescribed.
Patients who have exhausted prescription drug coverage or who are uninsured may require …

Introduction Statins are the primary therapeutic approach for treating hypercholesterolemia
in hyperlipidemic high cardiovascular-risk patients, as stated by the recent European and …

For approximately 30 years, statins have been effectively used to control cholesterol, thereby
reducing the morbidity and mortality associated with cardiovascular disease. Evidence …

The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are
effective in reducing the risk of coronary events, and are generally very well tolerated …

Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The
most important adverse effects associated with statins are myopathy and an asymptomatic …